Eye Health, Glaucoma & Vision Disorders • ICD-10-CM H49.20

Sixth (abducens) nerve palsy

Name: Sixth (abducens) nerve palsy (ICD-10 H49.20): Biomarkers, Clinical Protocols & Wholesale Cash Pricing
Published: 2026-11-02

Also known as: Abducens nerve palsy

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2026-11-02 • ICD-10-CM H49.20 • 4 Linked .gov / PubMed Citations • Governance: Dr. Devon Caldwell, DO, MPH (NPI #1568063758)

Methodology & AI Transparency ⓘ

Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.

At a Glance • Plain-English Clinical Summary

Sixth (abducens) nerve palsy Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

1 What it does: Sixth (abducens) nerve palsy (also termed Abducens nerve palsy)—coded clinically as H49.20 across Eyes & Vision guidelines—combines slit-lamp biomicroscopy [Sixth (abducens) nerve palsy H49.20] with structured follow-up of Best-Corrected Visual Acuity in Sixth (abducens) nerve palsy (H49.20: & OCT) (Intact retinal nerve fiber & macula (H49.20)).
2 Real-world patient consensus: Diagnostic registry H49.20: Sixth (abducens) nerve palsy is managed within Eyes & Vision (aka Abducens nerve palsy).
3 Typical cash cost range: Primary evaluation for Sixth (abducens) nerve palsy incorporates slit-lamp biomicroscopy [Sixth (abducens) nerve palsy H49.20] and symptom diary review.
4 Top reported side effects / signs: Follow-up benchmark in Sixth (abducens) nerve palsy: maintaining Intraocular Pressure (IOP) [Sixth (abducens) nerve palsy H49.20] within 10 – 21 mmHg (individualized optic target) (H49.20).

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Sixth (abducens) nerve palsy

3 of 3 Free Questions Remaining

What Is Sixth (abducens) nerve palsy?

Sixth (abducens) nerve palsy (also termed Abducens nerve palsy)—coded clinically as H49.20 across Eyes & Vision guidelines—combines slit-lamp biomicroscopy [Sixth (abducens) nerve palsy H49.20] with structured follow-up of Best-Corrected Visual Acuity in Sixth (abducens) nerve palsy (H49.20: & OCT) (Intact retinal nerve fiber & macula (H49.20)).

Pathophysiology, Underlying Causes & Clinical Presentation

Underlying Sixth (abducens) nerve palsy (code H49.20) is microvascular diabetic/hypertensive retinopathy [Sixth (abducens) nerve palsy H49.20], which Eye Health, Glaucoma & Vision Disorders clinicians address while surveilling Intraocular Pressure (IOP) [Sixth (abducens) nerve palsy H49.20] (10 – 21 mmHg (individualized optic target) (H49.20)).

Common Symptoms & Clinical Signs

• Presentation of Sixth (abducens) nerve palsy (H49.20): gritty burning, foreign-body in Sixth (abducens) nerve palsy (H49.20: sensation, reflex tearing,)
• Secondary Sixth (abducens) nerve palsy clinical sign: loss of peripheral in Sixth (abducens) nerve palsy (H49.20: side vision)
• Symptom flares in Sixth (abducens) nerve palsy correlating with Intraocular Pressure (IOP) [Sixth (abducens) nerve palsy H49.20] deviation outside 10 – 21 mmHg (individualized optic target) (H49.20)
• Functional eyes & vision impact requiring slit-lamp biomicroscopy [Sixth (abducens) nerve palsy H49.20] evaluation (H49.20)

Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗

Sixth (abducens) nerve palsy Diagnostic Classification & Lab Markers

Metric	Verified Benchmark	Source
ICD-10-CM Diagnostic Code	H49.20	WHO / CMS ICD-10-CM Clinical Classification
Clinical Specialty Hub	Eye Health, Glaucoma & Vision Disorders	NIH MedlinePlus Health Topics
Diagnostic / Lab Marker: Intraocular Pressure (IOP) [Sixth (abducens) nerve palsy H49.20]	10 – 21 mmHg (individualized optic target) (H49.20)	Clinical Reference Target Range
Diagnostic / Lab Marker: Best-Corrected Visual Acuity in Sixth (abducens) nerve palsy (H49.20: & OCT)	Intact retinal nerve fiber & macula (H49.20)	Clinical Reference Target Range
Diagnostic / Lab Marker: HbA1c & Systemic in Sixth (abducens) nerve palsy (H49.20: Blood Pressure)	Microvascular retinal protection (H49.20)	Clinical Reference Target Range

Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance

FDA-Monographed Medications & Public Cash Price Reference for Sixth (abducens) nerve palsy

Check Drug Interactions →

Treatment selection for Sixth (abducens) nerve palsy depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.

Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Sixth (abducens) nerve palsy)

Browse All PubMed Translations →

Study & Plain-English Finding	Sample (N)	Rigor	Primary Source
Can This Approach Help? Inside the Latest Research on Long-Term safety and real-world benefits of Perfluorohexyloctane Ophthalmic PFHO was safe and well tolerated and maintained efficacy for improving signs and symptoms of DED in this year-long study of patients with DED associated with Meibomian gland dysfunction. Cornea • 2024-09-01 • Phase III Randomized Trial	N = 97	82/100	PMID 37921522 ↗

Zero-PHI Patient Support & Cohort Discussions

Sixth (abducens) nerve palsy Patient Community & “People Like Me” Threads

“People Like Me” Cohort Filter (Zero-PHI)

Filter Sixth (abducens) nerve palsy community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Sixth (abducens) nerve palsy.

Related Conditions in Eye Health, Glaucoma & Vision Disorders